Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers February 27, 2017
Pharmacy Choice - News - Generic Drugs - February 27, 2017

Pharmacy News

 Generic Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 47     Next >>     Go To Page:

2/25/17 - Intellipharmaceutics Announces FDA Approval for 500 mg and 750 mg Generic Glucophage XR [T-break Tech (Middle East)]
Intellipharmaceutics International Inc., a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs announced that the Company today received final approval from the U.S. Food and Drug Administration for the Company`s abbreviated new drug...
2/25/17 - Perrigo Confirms Patent Challenge For Generic Version Of Onexton Gel
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week Perrigo Company plc announced that it has filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration for clindamycin, benzoyl peroxide topical gel, the generic version of Onexton gel. Perrigo has notified Valeant Pharmaceuticals North America LLC
2/24/17 - ALLERGAN PLC - 10-K - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The results of Warner Chilcott Limited are consolidated into the results of Allergan plc. Due to the de minimis activity between Allergan plc and Warner Chilcott Limited, references throughout this section relate to both Allergan and Warner Chilcott Limited. Warner Chilcott Limited is an indirect wholly-owned subsidiary of Allergan plc and has the
2/24/17 - ANI Pharmaceuticals Acquires Inderal XL and InnoPran XL
ANI Pharmaceuticals, Inc. today announced that it has acquired Inderal XL from Cranford Pharmaceuticals, LLC and InnoPran XL from Holmdel Pharmaceuticals LP. Inderal XL and InnoPran XL generated combined sales of $23.3 million in calendar year 2016, according to IMS Health. Arthur S. Przybyl, ANI's President and CEO stated, "We are ex
2/24/17 - Biosimilars 2017 Global Market Expected to Grow at CAGR 55.52% And Forecast To 2020
PUNE, INDIA, February 23, 2017/ EINPresswire.com/ Global Biosimilars Market Biosimilars are defined as the follow-on versions of original biological medicines. They have many similarities, but are not identical to, the reference biopharmaceutical product. Covered in this report The report covers the present scenario and the growth prospects of th
2/24/17 - Findings from Brigham and Women's Hospital Yields New Findings on Antiepileptics (Switching generic antiepileptic drug manufacturer not linked to...
By a News Reporter-Staff News Editor at Drug Week Current study results on Drugs and Therapies- Antiepileptics have been published. According to news originating from Boston, Massachusetts, by NewsRx correspondents, research stated, "With more antiepileptic drugs becoming available in generic form, we estimated the risk of seizure-related events.
2/24/17 - Intellipharmaceutics Announces FDA Approval for 500 mg and 750 mg Generic Glucophage XR
Intellipharmaceutics International Inc., a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs announced that the Company today received final approval from the U.S. Food and Drug Administration for the Company's abbreviated new drug.
2/24/17 - MAYNE PHARMA DELIVERS EXCEPTIONAL 2017 HALF YEAR PERFORMANCE
Release date- 23022017- Commenting on the half year result, Mayne Pharma's CEO, Mr Scott Richards said,' We are very pleased to be announcing strong results for Mayne Pharma across all key financial metrics, with the Group reporting exceptional growth across revenue, EBITDA and net profit on the prior corresponding period.'. The underlying Generic
2/24/17 - NetworkNewsBreaks Intellipharmaceutics International, Inc. (NASDAQ: IPCI) Shares Higher on FDA Approval of Two Strengths of Generic Glucophage XR
Intellipharmaceutics International shares were up 27% this morning following news that it has received final approval for its abbreviated new drug application for metformin hydrochloride extended release tablets in the 500 mg and 750 mg strengths from the U.S. Food and Drug Administration. We are actively evaluating options to realize commercial...
2/24/17 - New Partnership Set to Help 'Transform' Access to Medicines for Patients in Greater Manchester
The collaboration, in the form of a Memorandum of Understanding, will create a Greater Manchester and Pharmaceutical Industry Partnership Group. The agreement will allow Greater Manchester to explore new ways of paying for medicines based on patient outcomes- enabling the Pounds1 billion spent on medicines in the region to be as effective as possib
2/24/17 - Pernix Therapeutics Prevails in Zohydro ER ANDA Litigation [Tehran Times (Iran)]
-Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company with a focus on Pain and CNS conditions, announced today that it received a favorable opinion in its litigation with Actavis Laboratories FL, Inc. regarding a proposed generic version of Zohydro ER. Judge Gregory M. Sleet of the United States District Court for the District of
2/24/17 - Researchers at Hanyang University Have Reported New Data on Rheumatoid Arthritis [Efficacy and safety of CT-P13 (biosimilar infliximab) in patients...
By a News Reporter-Staff News Editor at Health& Medicine Week Investigators publish new report on Autoimmune Diseases and Conditions- Rheumatoid Arthritis. According to news reporting out of Seoul, South Korea, by NewsRx editors, research stated, "To assess the efficacy and safety of switching from the infliximab reference product to its biosimil
2/24/17 - Tablet Packing Machine Market Volume Analysis by End-Use Industry 2017-2027
Tablet Packing Machine Market: Global Industry Analysis, Size and Forecast, 2017 to 2027 Research Report By Future Market InsightsValley Cottage, NY 02/24/2017 Introduction:. The growth in the global pharmaceutical industry has led to the growth in the pharmaceutical machines industry, which in turn has escalated the demand in tablet packing
2/24/17 - WARNER CHILCOTT LTD - 10-K - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The results of Warner Chilcott Limited are consolidated into the results of Allergan plc. Due to the de minimis activity between Allergan plc and Warner Chilcott Limited, references throughout this section relate to both Allergan and Warner Chilcott Limited. Warner Chilcott Limited is an indirect wholly-owned subsidiary of Allergan plc and has the
2/23/17 - Breaking Down The Multiple Sclerosis 2017 Formularies: 'Stability Fares Well For The Market'
Initially, the treatment options included injectable therapy such as Teva Pharmaceutical Industries Ltd' s Copaxone and three beta-interferons, namely Merck& Co., Inc.' s Rebif, Biogen Inc' s Avonex and Bayer AG Betaseron. The injectable treatment option later expanded to Novartis AG' s Extavia, Biogen's Plegridy and Glatopa, the generic version of
2/23/17 - Cadila Healthcare receives approval from USFDA [India Infoline News Service]
Cadila Healthcare has received approval from US Food& Drug Administration to initiate Phase II clinical studies of Saroglitazar Magnesium in patients suffering from Primary Biliary. Cadila Healthcare has received approval from US Food& Drug Administration to initiate Phase II clinical studies of Saroglitazar Magnesium in patients suffering from...
2/23/17 - China Exclusive: Chinese affordable lung cancer drug hits market [Philippines News Agency]
Its release ends an almost decade-long monopoly by Iressa, developed by British multinational biopharmaceutical company AstraZeneca and introduced to China in 2005.. Yiruike was approved for marketing by China's State Food and Drug Administration after Iressa's patent protection expired in April 2016, Qilu sources said. The drug is a much-needed fi
2/23/17 - First biosimilar mAb in oncology granted EU approval
The European Commission has approved Truxima (biosimilar rituximab) for all indications of reference rituximab in the European Union (EU)...
2/23/17 - Hearing: #SubHealth to Look at User Fees
Greg Walden, R- Ore., chairman of the House Energy and Commerce Committee, issued the following news release:. Michael C. Burgess, M.D., announced a hearing for Thursday, March 2, 2017, at 10 a.m. in room 2123 of the Rayburn House Office Building. Both the Generic Drug User Fee Amendments of 2012 and the Biosimilar User Fee Act of 2012 expire in Se
2/23/17 - HEARING: #SubHealth to Look at User Fees NEXT WEE
Michael C. Burgess, M.D., announced a hearing for Thursday, March 2, 2017, at 10 a.m. in room 2123 of the Rayburn House Office Building. Both the Generic Drug User Fee Amendments of 2012 and the Biosimilar User Fee Act of 2012 expire in September 2017, and must be reauthorized for the Fiscal Years 2018-2022. GDUFA was enacted with the goal of signi
2/23/17 - MAYNE PHARMA LAUNCHES METHYLPHENIDATE EXTENDED-RELEASE 60MG CAPSULES IN THE UNITED STATES
Mayne Pharma's CEO Scott Richards said,' This will be the first generic alternative of the 60 mg dose strength, providing more choices to patients in terms of medication affordability. The launch of methylphenidate is Mayne Pharma's sixth new product launch since the beginning of FY16.'. Mayne Pharma directly markets more than 50 products and has a
2/23/17 - Pernix Therapeutics Prevails in Zohydro ER ANDA Litigation
Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company with a focus on Pain and CNS conditions, announced today that it received a favorable opinion in its litigation with Actavis Laboratories FL, Inc. regarding a proposed generic version of Zohydro ER. Judge Gregory M. Sleet of the United States District Court for the District of
2/22/17 - Avid Bioservices to Participate at Upcoming Life Sciences Industry Conferences
Avid Bioservices, Inc., a wholly owned subsidiary of Peregrine Pharmaceuticals, Inc., today announced that the company will attend and participate at two upcoming life sciences industry conferences. On March 14, 2017, David Briggs, Ph.D., a scientist in Avid s process sciences department, will discuss the expanding role of pre-packed columns i
2/22/17 - Branded Generics Market Is Projected To Grow Exponentially As Large Number Of New Pharmaceutical Products Till 2025: Grand View Research, Inc.
According to new report by Grand View Research, The global branded generics market is projected to grow gradually as large number of pharmaceutical products are going to go off patent within the forecast period of 2014 to 2025.. Branded drugs are patented drugs. When a pharmaceutical company discovers a new drug, it files for a patent.
2/22/17 - Heritage Appoints Scott Delaney As President
Heritage Pharmaceuticals Inc., an Eatontown- based specialty generic pharmaceutical company, is pleased to announce the appointment of Scott Delaney as its President, effective March 1, 2017.
Articles(s): 1 - 25 of 47     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415